183 related articles for article (PubMed ID: 36985531)
21. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
23. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of khellactone coumarin derivatives isolated from Peucedanum japonicum Thurnberg.
Heo JH; Eom BH; Ryu HW; Kang MG; Park JE; Kim DY; Kim JH; Park D; Oh SR; Kim H
Sci Rep; 2020 Dec; 10(1):21695. PubMed ID: 33303801
[TBL] [Abstract][Full Text] [Related]
24. Cholinesterase Inhibition Activity, Alkaloid Profiling and Molecular Docking of Chilean
Tallini LR; Bastida J; Cortes N; Osorio EH; Theoduloz C; Schmeda-Hirschmann G
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949847
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
[TBL] [Abstract][Full Text] [Related]
26. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
Feng B; Li X; Xia J; Wu S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
[TBL] [Abstract][Full Text] [Related]
27. New amide and diterpene alkaloids with anticholinesterase activity from Delphinium cyphoplectrum roots.
Salehi A; Zolfaghari B; Aghaei M; Sirous H; Sadeghi M; Gholami MR; Reisi P; Ghanadian M
Daru; 2024 Jun; 32(1):237-251. PubMed ID: 38498253
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
[TBL] [Abstract][Full Text] [Related]
29. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Altıntop MD; Gurkan-Alp AS; Ozkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 Aug; 346(8):571-6. PubMed ID: 23881696
[TBL] [Abstract][Full Text] [Related]
31. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
Miao S; He Q; Li C; Wu Y; Liu M; Chen Y; Qi S; Gong K
Pharm Biol; 2022 Dec; 60(1):1502-1510. PubMed ID: 35968601
[TBL] [Abstract][Full Text] [Related]
32. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity.
Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719
[TBL] [Abstract][Full Text] [Related]
33. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents.
Koca M; Yerdelen KO; Anil B; Kasap Z; Sevindik H; Ozyurek I; Gunesacar G; Turkaydin K
J Enzyme Inhib Med Chem; 2016; 31(sup2):13-23. PubMed ID: 27226239
[TBL] [Abstract][Full Text] [Related]
35. Two new dilactonized glycerol glycosides of the dual anticholinesterase active extract from Ocotea daphnifolia using bioguided fractionation and molecular docking studies.
Luz RLSA; Almeida RBM; Albuquerque MMS; Cerqueira APM; Tavares JF; Silva MSD; Filho RB; Dos Santos Junior MC; Branco A; Botura MB
Chem Biol Drug Des; 2023 Apr; 101(4):855-864. PubMed ID: 36527177
[TBL] [Abstract][Full Text] [Related]
36. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.
Krátký M; Štěpánková Š; Brablíková M; Svrčková K; Švarcová M; Vinšová J
Curr Top Med Chem; 2020; 20(23):2106-2117. PubMed ID: 32814531
[TBL] [Abstract][Full Text] [Related]
37. Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease.
Kaur S; Bansal Y
Bioorg Chem; 2022 Apr; 121():105670. PubMed ID: 35189442
[TBL] [Abstract][Full Text] [Related]
38. Computational Approaches to Evaluate the Acetylcholinesterase Binding Interaction with Taxifolin for the Management of Alzheimer's Disease.
Ahmad V; Alotibi I; Alghamdi AA; Ahmad A; Jamal QMS; Srivastava S
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338420
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study.
Rahim F; Ullah H; Taha M; Hussain R; Sarfraz M; Iqbal R; Iqbal N; Khan S; Ali Shah SA; Albalawi MA; Abdelaziz MA; Alatawi FS; Alasmari A; Sakran MI; Zidan N; Jafri I; Khan KM
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615218
[TBL] [Abstract][Full Text] [Related]
40. Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease.
Jiang X; Zhang Z; Zuo J; Wu C; Zha L; Xu Y; Wang S; Shi J; Liu XH; Zhang J; Tang W
Eur J Med Chem; 2021 Nov; 223():113735. PubMed ID: 34371367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
